iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 63.7% in January

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totaling 1,641 shares, a drop of 63.7% from the December 31st total of 4,523 shares. Based on an average daily volume of 1,499 shares, the short-interest ratio is currently 1.1 days. Approximately 1.1% of the company’s stock are short sold. Approximately 1.1% of the company’s stock are short sold. Based on an average daily volume of 1,499 shares, the short-interest ratio is currently 1.1 days.

iShares Neuroscience and Healthcare ETF Price Performance

NYSEARCA IBRN opened at $33.37 on Wednesday. iShares Neuroscience and Healthcare ETF has a 1 year low of $17.86 and a 1 year high of $37.00. The company has a market cap of $5.01 million, a price-to-earnings ratio of 15.61 and a beta of 0.93. The stock’s fifty day moving average price is $31.96 and its 200 day moving average price is $28.19.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.